Search results for: 'land test impact of evolving cloud'

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides a comprehensive overview of breakthrough innovations reshaping drug discovery, diagnostics, and therapeutic delivery across oncology, infectious diseases, rare and autoimmune disorders, metabolic and age-related conditions, neurodegenerative and neuromu...

This study provides an in-depth examination of recent advancements in next-generation terahertz (THz) imaging and sensing technologies and their increasingly transformative impact across healthcare diagnostics and security-related applications. It focuses on how emerging THz systems, enabled by significant progress in quantum cascade lasers (QCLs),...

Qualified respondents to this Frost & Sullivan survey were invited to participate in a telephone interview examining their laboratory’s product purchasing process in 2024 and expectations for 2025. Frost & Sullivan has conducted similar studies among the same targeted respondents since 2012. The survey provides companies with actionable and trendin...

This study focuses on emerging pharmacological and non-pharmacological strategies in the treatment of obesity, as well as evolving new paradigms for the future. It describes the contribution of incretin-based therapies, particularly GLP-1 receptor agonists and their multi-agonist counterparts, which provide robust effects on weight loss and metabol...

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) comprise innovation insights across antibody and cellular therapies. The study also encompasses recent innovations in liquid biopsy tests, drug delivery and drug discovery platforms.The Life Science, Health & Wellness TOE will feature disruptive technology advan...

The global life sciences laboratory information management systems (LIMS) industry is forecast to grow from 2026 to 2031 at a CAGR of 8.5%, driven by the increasing need for laboratory automation, regulatory compliance, and cloud-based solutions. Leading players in the global life sciences LIMS market, including LabWare, Benchling, Clinisys, LabVan...

Qualified respondents to this Frost & Sullivan survey were invited to participate in an online survey examining their laboratory’s product purchasing process in 2025 and expectations for 2026. Frost & Sullivan has conducted similar studies among the same target respondent groups since 2012. The survey provides companies with actionable trend insigh...

Worldwide cancer incidence is expected to exceed 35 million new cases by 2050, a 77% rise from the 20 million cases in 2022. Alcohol intake, tobacco usage, obesity, and air pollution are the main causes of this increase. Cancer studies today emphasize cell and gene therapy, antibody-drug conjugates (ADCs), checkpoint inhibitors, and multi-specific...

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides insights across recent developments in female contraception technique, small molecule drugs, cell and gene therapies, cancer diagnosis and treatment and nanobody technologies. The research also encompasses emerging innovations across infectious and immu...